Discrepancies between transcutaneous and serum bilirubin measurements
- PMID: 25601981
- PMCID: PMC4306797
- DOI: 10.1542/peds.2014-1919
Discrepancies between transcutaneous and serum bilirubin measurements
Abstract
Objective: To characterize discrepancies between transcutaneous bilirubin (TcB) measurements and total serum bilirubin (TSB) levels among newborns receiving care at multiple nursery sites across the United States.
Methods: Medical records were reviewed to obtain data on all TcB measurements collected during two 2-week periods on neonates admitted to participating newborn nurseries. Data on TSB levels obtained within 2 hours of a TcB measurement were also abstracted. TcB--TSB differences and correlations between the values were determined. Data on demographic information for individual newborns and TcB screening practices for each nursery were also collected. Multivariate regression analysis was used to identify characteristics independently associated with the TcB--TSB difference.
Results: Data on 8319 TcB measurements were collected at 27 nursery sites; 925 TSB levels were matched to a TcB value. The mean TcB--TSB difference was 0.84 ± 1.78 mg/dL, and the correlation between paired measurements was 0.78. In the multivariate analysis, TcB--TSB differences were 0.67 mg/dL higher in African-American newborns than in neonates of other races (P < .001). The TcB--TSB difference also varied significantly based on brand of TcB meter used and hour of age of the infant. For 2.2% of paired measurements, the TcB measurement underestimated the TSB level by ≥ 3 mg/dL.
Conclusions: During routine clinical care, TcB measurement provided a reasonable estimate of TSB levels in healthy newborns. Discrepancies between TcB and TSB levels were increased in African-American newborns and varied based on brand of meter used.
Keywords: jaundice; neonates; transcutaneous bilirubin.
Copyright © 2015 by the American Academy of Pediatrics.
Figures
Comment in
-
Transcutaneous bilirubin measurement: does it work in the real world?Pediatrics. 2015 Feb;135(2):364-6. doi: 10.1542/peds.2014-3472. Pediatrics. 2015. PMID: 25601975 No abstract available.
References
-
- Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF. Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications. Pediatrics. 2009;124(4):1193–1198 - PubMed
-
- Maisels MJ, Kring E. Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics. 1997;99(4):599–601 - PubMed
-
- NICE, National Institute for Health and Clinical Excellence. Recognition and treatment of neonatal jaundice. Available at: http://guidance.nice.org.uk/CG98. Accessed March 1, 2013
-
- Engle WD, Jackson GL, Sendelbach D, Manning D, Frawley WH. Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. Pediatrics. 2002;110(1 pt 1):61–67 - PubMed
-
- Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106(2). Available at: www.pediatrics.org/cgi/content/full/106/2/e17 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical